Overview

Mitomycin C Therapy for Patients With Primary Sclerosing Cholangitis

Status:
Unknown status
Trial end date:
2019-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness and safety of mitomycin C in the treatment of primary sclerosing cholangitis (PSC).
Phase:
Phase 2
Details
Lead Sponsor:
Li, Zhiping, M.D.
Collaborator:
Johns Hopkins University
Treatments:
Mitomycin
Mitomycins